tiprankstipranks
Cogent Biosciences (COGT)
NASDAQ:COGT
US Market

Cogent Biosciences (COGT) Income Statement

Compare
558 Followers

Cogent Biosciences Income Statement

Last quarter (Q3 2024), Cogent Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Cogent Biosciences's net income was $-70.63M. See Cogent Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 7.87M$ 22.50M
Gross Profit
$ -3.59M$ -5.88M$ -147.00K$ 7.85M$ 22.46M
Operating Expenses
$ 208.13M$ 147.84M$ 75.55M$ 90.07M$ 54.68M
Depreciation and Amortization
$ 2.27M$ 5.88M$ 147.00K$ 720.00K$ 1.29M
EBITDA
$ -205.86M$ -134.36M$ -75.40M$ -34.57M$ -30.89M
Operating Income
$ -208.13M$ -147.84M$ -75.55M$ -82.20M$ -32.18M
Other Income/Expenses
$ 15.72M$ 7.60M$ 3.28M$ 7.39M$ 345.00K
Pretax Income
$ -192.41M$ -140.24M$ -72.27M$ -74.81M$ -31.83M
Net Income
$ -192.41M$ -132.64M$ -71.81M$ -66.45M$ -30.27M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.42$ -2.26$ -1.85$ -6.00$ -3.97
Diluted EPS
$ -2.42$ -2.26$ -1.85$ -6.00$ -3.97
Weighted Average Shares Outstanding
79.66M 58.74M 38.73M 11.08M 7.62M
Weighted Average Shares Outstanding (Diluted)
79.66M 58.74M 38.73M 11.08M 7.62M
Currency in USD

Cogent Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis